314 related articles for article (PubMed ID: 19815416)
1. Primary anaplastic pilocytic astrocytoma.
Azad A; Deb S; Cher L
J Clin Neurosci; 2009 Dec; 16(12):1704-6. PubMed ID: 19815416
[TBL] [Abstract][Full Text] [Related]
2. Hemorrhagic onset of pilocytic astrocytoma and pilomyxoid astrocytoma.
Shibahara I; Kanamori M; Kumabe T; Endo H; Sonoda Y; Ogawa Y; Watanabe M; Tominaga T
Brain Tumor Pathol; 2009; 26(1):1-5. PubMed ID: 19408090
[TBL] [Abstract][Full Text] [Related]
3. Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas.
Parsa CF; Givrad S
Br J Ophthalmol; 2008 Jan; 92(1):40-6. PubMed ID: 17962395
[TBL] [Abstract][Full Text] [Related]
4. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
5. Development of anaplastic changes in low-grade astrocytomas of childhood.
Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
[TBL] [Abstract][Full Text] [Related]
6. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
7. Regression of grade III astrocytoma during the treatment of CML with imatinib mesylate.
Jayawardena S; Sooriabalan D; Indulkar S; Kim HH; Matin A; Maini A
Am J Ther; 2006; 13(5):458-9. PubMed ID: 16988542
[TBL] [Abstract][Full Text] [Related]
8. Pilocytic astrocytoma with spontaneous intracranial hemorrhages in an elderly adult.
Lyons MK
Clin Neurol Neurosurg; 2007 Jan; 109(1):76-80. PubMed ID: 16621238
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
10. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
Perry A; Aldape KD; George DH; Burger PC
Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
[TBL] [Abstract][Full Text] [Related]
11. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
Patt S; Giraldo M; Martin H
Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
[TBL] [Abstract][Full Text] [Related]
12. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
13. Expression of Fas/APO-1 during the progression of astrocytomas.
Tachibana O; Nakazawa H; Lampe J; Watanabe K; Kleihues P; Ohgaki H
Cancer Res; 1995 Dec; 55(23):5528-30. PubMed ID: 7585627
[TBL] [Abstract][Full Text] [Related]
14. Transformation of juvenile pilocytic astrocytoma to anaplastic pilocytic astrocytoma in patients with neurofibromatosis type I.
Peters KB; Cummings TJ; Gururangan S
J Pediatr Hematol Oncol; 2011 Jul; 33(5):e198-201. PubMed ID: 21572348
[TBL] [Abstract][Full Text] [Related]
15. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors.
Barker FG; Chang SM; Huhn SL; Davis RL; Gutin PH; McDermott MW; Wilson CB; Prados MD
Cancer; 1997 Sep; 80(5):936-41. PubMed ID: 9307194
[TBL] [Abstract][Full Text] [Related]
16. Primary cerebellar pilocytic astrocytoma with anaplastic features in a patient with neurofibromatosis type 1 - case report - .
Tsuda K; Ishikawa E; Saito A; Satomi K; Sakata A; Takano S; Morishita Y; Noguchi M; Matsumura A
Neurol Med Chir (Tokyo); 2011; 51(4):315-8. PubMed ID: 21515958
[TBL] [Abstract][Full Text] [Related]
17. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
[TBL] [Abstract][Full Text] [Related]
18. Pilocytic astrocytoma presenting as an intrinsic brainstem tumor: case report and review of the literature.
Shaya MR; Fowler MR; Nanda A
J La State Med Soc; 2004; 156(1):33-6. PubMed ID: 15000211
[TBL] [Abstract][Full Text] [Related]
19. J1-31 protein expression in astrocytes and astrocytomas.
Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas.
Amatya VJ; Akazawa R; Sumimoto Y; Takeshima Y; Inai K
Pathol Int; 2009 Feb; 59(2):80-5. PubMed ID: 19154260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
